|
|
|
|
| LEADER |
00000cam a2200000xi 4500 |
| 001 |
b11622533 |
| 003 |
CoU |
| 005 |
20210528104442.2 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
170719s2017 flu ob 001 0 eng d |
| 019 |
|
|
|a 1066648488
|a 1077307401
|a 1084344706
|
| 020 |
|
|
|a 9781315356211
|q (electronic bk.)
|
| 020 |
|
|
|a 131535621X
|q (electronic bk.)
|
| 020 |
|
|
|a 9781315373669
|q (ebook)
|
| 020 |
|
|
|a 1482220849
|
| 020 |
|
|
|a 9781482220841
|
| 020 |
|
|
|a 1315373661
|
| 020 |
|
|
|a 9781315373669
|
| 020 |
|
|
|z 9781482220834
|
| 020 |
|
|
|z 1482220830
|
| 024 |
0 |
|
|a 40027334531
|
| 035 |
|
|
|a (OCoLC)tfe994145931
|
| 035 |
|
|
|a (OCoLC)994145931
|z (OCoLC)1066648488
|z (OCoLC)1077307401
|z (OCoLC)1084344706
|
| 037 |
|
|
|a tfe9781315373669
|
| 040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d OCLCO
|d CRCPR
|d YDX
|d OCLCO
|d IDEBK
|d UIU
|d UAB
|d MERER
|d OCLCQ
|d U3G
|d OCLCO
|d OCLCQ
|d STF
|d CAUOI
|d OCLCQ
|d U3W
|d NLE
|d UKMGB
|d COO
|d WYU
|d OCLCO
|d OCLCA
|d VT2
|d TYFRS
|d OCLCQ
|d UKAHL
|d OCLCF
|d OCLCQ
|d OCLCO
|
| 049 |
|
|
|a GWRE
|
| 050 |
|
4 |
|a RM301.25
|b .D786148 2017eb
|
| 245 |
0 |
0 |
|a Drug repositioning :
|b approaches and applications for neurotherapeutics /
|c [edited by] Joel Dudley and Laura Berliocchi.
|
| 264 |
|
1 |
|a Boca Raton :
|b CRC Press,
|c [2017]
|
| 300 |
|
|
|a 1 online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent.
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia.
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier.
|
| 490 |
1 |
|
|a Frontiers in neurotherapeutics series.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
0 |
|t Chapter 1 Scientific and Commercial Value of Drug Repurposing /
|r David Cavalla --
|t chapter 2 Repurposing for Alzheimer's and Parkinson's Diseases --
|t The Ideas, the Pipeline, the Successes, and the Disappointments /
|r Hermann Mucke --
|t chapter 3 Contribution of Not-for-Profit Organizations to Drug Repurposing /
|r Bruce Bloom --
|t section I The Rationale and Economics of Drug Repositioning --
|t chapter 4 Systematic Drug Repositioning /
|r Spyros N. Deftereos Aris Persidis Andreas Persidis Eftychia Lekka Christos Andronis Vassilis Virvillis --
|t chapter 5 Technical Tools for Computational Drug Repositioning /
|r Francesco Napolitano --
|t chapter 6 RNAi Screening toward Therapeutic Drug Repurposing /
|r Nichole Orr-Burks Byoung-Shik Shim Olivia Perwitasari Ralph A. Tripp --
|t chapter 7 Phenotypic Screening /
|r Christine M. Macolino-Kane John R. Ciallella Christopher A. Lipinski Andrew G. Reaume --
|t section II Repositioning Approaches and Technologies From Serendipity to Systematic and Rational Strategies --
|t chapter 8 A Case Study --
|t Chlorpromazine /
|r Francisco López-Muñoz Cecilio Álamo Silvia E. García-Ramos --
|t chapter 9 Drug Repurposing for Central Nervous System Disorders --
|t A Pillar of New Drug Discovery /
|r Mondher Toumi Aleksandra Caban Anna Kapuśniak Szymon Jarosławski Cecile Rémuzat --
|t chapter 10 Repurposing Opportunities for Parkinson's Disease Therapies /
|r Giulia Ambrosi Silvia Cerri Fabio Blandini --
|t chapter 11 Drug Candidates for Repositioning in Alzheimer's Disease /
|r Maria P. del Castillo-Frias Andrew J. Doig --
|t chapter 12 Promising Candidates for Drug Repurposing in Huntington's Disease /
|r Francesca Romana Fusco Emanuela Paldino --
|t chapter 13 Drug Repositioning Opportunities in Psychiatry /
|r Alexander W. Charney Joseph R. Scarpa Douglas M. Ruderfer Dennis S. Charney --
|t chapter 14 Pharmacology of Amyotrophic Lateral Sclerosis --
|t Old Strategies and New Perspectives /
|r Tiziana Petrozziello Valentina Tedeschi Alba Esposito Agnese Secondo --
|t chapter 15 Repositioning Clinic-Ready Compounds for the Treatment of Spinal Muscular Atrophy /
|r Faraz Farooq --
|t chapter 16 Rescuing Ischemic Brain Injury by Targeting the Immune Response through Repositioned Drugs /
|r Diana Amantea Giacinto Bagetta --
|t section III Drug Repositioning for Nervous System Diseases.
|
| 588 |
0 |
|
|a Print version record.
|
| 650 |
|
0 |
|a Drug development.
|0 http://id.loc.gov/authorities/subjects/sh97007921.
|
| 650 |
|
0 |
|a Neuropharmacology.
|0 http://id.loc.gov/authorities/subjects/sh85091157.
|
| 650 |
|
7 |
|a Drug development.
|2 fast
|0 (OCoLC)fst00898670.
|
| 650 |
|
7 |
|a Neuropharmacology.
|2 fast
|0 (OCoLC)fst01036458.
|
| 700 |
1 |
|
|a Dudley, Joel T.
|0 http://id.loc.gov/authorities/names/nb2013002505
|1 http://isni.org/isni/0000000401546021.
|
| 700 |
1 |
|
|a Berliocchi, Laura.
|0 http://id.loc.gov/authorities/names/n2016069817.
|
| 776 |
0 |
8 |
|i Print version:
|t Drug repositioning.
|d Boca Raton : CRC Press, [2017]
|z 9781482220834
|w (DLC) 2016059349
|w (OCoLC)967457094.
|
| 830 |
|
0 |
|a Frontiers in neurotherapeutics series.
|0 http://id.loc.gov/authorities/names/n2014188222.
|
| 856 |
4 |
0 |
|u https://colorado.idm.oclc.org/login?url=https://www.taylorfrancis.com/books/9781315373669
|z Full Text (via Taylor & Francis)
|
| 907 |
|
|
|a .b116225336
|b 07-01-21
|c 01-22-21
|
| 998 |
|
|
|a web
|b 06-22-21
|c b
|d b
|e -
|f eng
|g flu
|h 0
|i 1
|
| 907 |
|
|
|a .b116225336
|b 06-22-21
|c 01-22-21
|
| 944 |
|
|
|a MARS - RDA ENRICHED
|
| 915 |
|
|
|a -
|
| 956 |
|
|
|a Taylor & Francis Ebooks
|
| 956 |
|
|
|b Taylor & Francis All eBooks
|
| 999 |
f |
f |
|i 5aeefbf3-2368-5a9d-a587-24e580400adb
|s db752256-f3bd-5919-a9a0-d36ef1e10991
|
| 952 |
f |
f |
|p Can circulate
|a University of Colorado Boulder
|b Online
|c Online
|d Online
|e RM301.25 .D786148 2017eb
|h Library of Congress classification
|i web
|n 1
|
